BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 141136)

  • 21. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss.
    Soulillou JP; Peyrat MA; Guenel J
    Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139
    [No Abstract]   [Full Text] [Related]  

  • 22. [Demonstration of new class I antigens in man].
    Fauchet R; Boscher MY; Merdrignac G; Bouhallier O; Charron DJ; Paul P; Cohen D; Genetet B
    Pathol Biol (Paris); 1987 Dec; 35(10):1325-32. PubMed ID: 2963994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of human T cell subsets identified by alloantisera.
    Ferrara GB; Strelkauskas AJ; Longo A; McDowell J; Yunis EJ; Schlossman SF
    J Immunol; 1979 Sep; 123(3):1272-7. PubMed ID: 381520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro interaction with antigen suppresses the differentiation of chronic lymphocytic leukemia cells secreting monoclonal anti-sheep red blood cell antibody.
    Fiorilli M; Misiti J; Pandolfi F; Semenzato G; Waldmann TA
    J Immunol; 1983 Oct; 131(4):2046-9. PubMed ID: 6225803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. I and i antigens on normal human T and B lymphocytes and on lymphocytes from patients with chronic lymphocytic leukemia.
    Shumak KH; Rachkewich RA; Greaves MF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):241-7. PubMed ID: 1095264
    [No Abstract]   [Full Text] [Related]  

  • 26. Fate of HL-A antigens and antibodies at the lymphocyte surface.
    Cullen SE; Bernoco D; Carbonara AO; Jacot-Guillarmod H; Trinchieri G; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1835-47. PubMed ID: 4130085
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocyte functions of child patients with ALL (acute lymphoblastic leukemia) in remission.
    Suzuki M
    Jpn J Clin Oncol; 1984 Mar; 14(1):31-40. PubMed ID: 6231391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Report on the second new world B-cell workshop.
    Thompson JS; Braun WE; Carpenter CB; Dossetor JB; Dupont B; Falk JA; Ferrone S; Johnson AH; Shaw JF; Sinal DP; Terasaki PI; Troup GM; Walford RL
    Transplant Proc; 1977 Mar; 9(1 Suppl 1):9-12. PubMed ID: 300930
    [No Abstract]   [Full Text] [Related]  

  • 29. The human major histocompatibility system.
    Thorsby E
    Transplant Rev; 1974; 18():51-129. PubMed ID: 4141523
    [No Abstract]   [Full Text] [Related]  

  • 30. [Locus HLA-DR--specific antigens of B lymphocytes. Comprehensive review].
    Májský A
    Vnitr Lek; 1978 Nov; 24(11):1092-1101. PubMed ID: 82296
    [No Abstract]   [Full Text] [Related]  

  • 31. Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation.
    Albrechtsen D; Arnesen E; Solheim BG; Thorsby E
    Transplant Proc; 1979 Mar; 11(1):743-7. PubMed ID: 156432
    [No Abstract]   [Full Text] [Related]  

  • 32. T-cell-specific human alloantisera to antigens segregating outside the major histocompatibility complex.
    Schacter B; Pollard K; Maylock R; Humphrey RL; Hsu SH; Bias WB
    Transplant Proc; 1977 Mar; 9(1):635-7. PubMed ID: 301310
    [No Abstract]   [Full Text] [Related]  

  • 33. Poor mixed lymphocyte reaction stimulatory capacity of leukemic B cells of chronic lymphocytic leukemia patients despite the presence of Ia antigens.
    Halper JP; Fu SM; Gottlieb AB; Winchester RJ; Kunkel HG
    J Clin Invest; 1979 Nov; 64(5):1141-8. PubMed ID: 159311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of HLA (Ia) and non-HLA specificities by "B-cell" antisera.
    Thompson JS; Severson CD; Greazel NA; Ferrone S
    Transplant Proc; 1977 Mar; 9(1):597-600. PubMed ID: 68591
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of new cell surface markers in man: the problem of immunogenicity.
    Ferrara GB
    Transplant Proc; 1979 Mar; 11(1):715-8. PubMed ID: 313101
    [No Abstract]   [Full Text] [Related]  

  • 36. [The specificity of leukocyte antibodies in histocompatibility testing of serum from prima- and multiparas].
    Bertrams J; Kuwert E; Lohmeyer HH
    Bibl Haematol; 1971; 37():98-106. PubMed ID: 5138931
    [No Abstract]   [Full Text] [Related]  

  • 37. Reactivity of HLA typing sera against cultured lymphoblastoid cell lines and purified peripheral B and T cells from the same original donors.
    Nakayama E; Itakura K
    Jpn J Exp Med; 1977 Oct; 47(5):425-7. PubMed ID: 304500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of human antibody-dependent cellular cytotoxicity (ADCC) in an allogenic system].
    Láng I; Fekete B; Gergely P; Petrányi G
    Orv Hetil; 1977 Jul; 118(30):1763-5. PubMed ID: 407541
    [No Abstract]   [Full Text] [Related]  

  • 39. Human leukemia antigen. I. Production and characterization of antisera.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
    [No Abstract]   [Full Text] [Related]  

  • 40. T and B membrane markers on blast cells in 69 patients with acute lymphoblastic leukemia.
    Brouet JC; Toben HR; Chevalier A; Seligmann M
    Ann Immunol (Paris); 1974; 125 C(5):691-6. PubMed ID: 4617552
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.